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Abstract  
 
Interaction between sinusoidal endothelial cells (SECs) and hepatocytes is a prerequisite for liver function.  
Upon tissue loss, both liver cell populations need to be regenerated. Repopulation occurs in a coordinated 
pattern, first through the regeneration of parenchyme (hepatocytes) which then produces VEGF to enable the 
subsequent angiogenic phase. The signals that instruct hepatocytes to induce timely VEGF remain unidentified. 
Given that liver is highly vascularized, we reasoned that fluctuations in oxygenation after tissue loss may 
contribute to the coordination between hepatocyte and SEC proliferation. To prevent drops in oxygen after 
hepatectomy, mice were pretreated with inositol trispyrophosphate (ITPP), an allosteric effector of hemoglobin 
causing increased O2-release from heme under hypoxic conditions. ITPP treatment delayed liver weight gain 
after hepatectomy. Comparison with controls revealed the presence of a hypoxic period around the peak of 
hepatocyte mitosis. Inhibition of hypoxia led to deficient hepatocyte mitosis, suppressed the regenerative Vegf 
wave, and abrogated the subsequent reconstruction of the sinusoidal network. These ITPP effects were ongoing 
with the reduction in hepatocellular Hif2a. In contrast, Hif1a was unaffected by ITPP. Hif2a knockdown 
phenocopied all effects of ITPP, including the mitotic deficiencies, Vegf suppression and angiogenic failure. 
Conclusions: Our study identifies oxygen as a key regulator of liver regeneration. Hypoxia - inherent to the 
expansion of parenchyme - activates Hif2a to couple hepatocyte mitosis with the angiogenic phase. Hif2a acts as 
a safeguard to initiate sinusoidal reconstruction only upon successful hepatocyte mitosis, thereby enforcing a 
timely order onto cell-type specific regeneration patterns. These findings portray the hypoxia-driven Hif2a-Vegf 
axis as a prime node in coordinating SEC-hepatocyte crosstalk during liver regeneration.  
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The reconstitution of liver following tissue loss requires the coordinate regeneration of all liver resident cells.
(1)
 
Hepatocytes form the parenchyme, the largest component of the liver, while sinusoidal endothelial cells (SECs) 
represent the major population of non-parenchymal liver cells. Removal of two thirds of the liver in rodents 
results in a complete recovery of hepatic volume within about a week
(2, 3)
 and encompasses two principal waves 
of proliferation.
(4, 5)
 In mouse, hepatocyte mitosis peaks around 48h and is followed by an angiogenic wave that 
leads to the reconstitution of the sinusoidal network within day 3 and 8 after resection.
(1, 6)
 The conserved 
sequence of these events points to the existence of a tightly controlled machinery that coordinates the timing of 
hepatocyte and SEC proliferation. Recent evidence has highlighted the importance of SECs in inducing and 
regulating parenchymal regeneration.
(6, 7)
 On the other hand, regenerating hepatocytes are the main providers of 
the key angiogenic molecule VEGF, which is essential for vascular reconstitution after tissue loss.
(4-6)
 What 
instructs hepatocytes to produce timely VEGF in regenerating liver is unknown.  
 
Hypoxia-inducible factors (HIFs) are prime transcriptional inducers of VEGF, however whether they do so 
during liver regeneration is unresearched. Under normoxia, the prolyl-hydroxylases (PHD) oxidize HIFs to 
promote their degradation, while low pO2 inhibits their hydroxylase activity leading to HIF stabilization and 
activation. HIFs however can also be activated by other cellular stresses and molecules in an O2-independent 
way.
(8)
 In mouse, Hif1a deletion from hepatocytes causes an initial delay in liver regeneration,
(9)
 while global 
knockout of Phd1 in mice accelerates the hepatocyte cell cycle,
(10)
 implying Hif1a may be a promoter of 
hepatocellular proliferation.  
 
It has been suggested that the liver remnant following tissue loss is floated with a disproportional volume of 
portal blood low in oxygen. Because the arterial supply does not change in relative terms,
(1)
 the portal inflow 
might cause hypoxia, perhaps leading to HIF stabilization. While hypoxia-driven initiation of hepatocyte 
proliferation is a conceivable view, the contribution of oxygen to the regulation of liver regeneration remains 
enigmatic.
(1),
 
(11, 12)
  
 
Here, we sought to clarify the role of hypoxia and HIFs in liver regeneration. More specifically, we explored 
whether the prevention of a hypoxic state impacts on the recovery of liver following tissue loss, and how 
hypoxia-dependent alterations in the regenerative process relate to hepatocyte proliferation and the subsequent 
angiogenic phase.  
 
5 
 
 
 
Materials and Methods 
 
Animals. All animal experiments were in accord with Swiss Federal Animal Regulations and approved by the 
Veterinary Office of Zürich (KEK-ZH -Nr. 2012-231). Male wild type mice (C57BL6, Harlan, Indiana, USA)  
aged 10-12 weeks were used and kept on a 12-hour day/night cycle with free access to food and water.  
 
Animal surgery. Isoflurane anesthesia, buprenorphine analgesia, followed by laparatomy and standard partial 
68% hepatectomy were performed as described.
(2) 
Following euthanasia, liver/body weight was recorded and 
organs were preserved in 4% formalin for histopathology or snap frozen in liquid nitrogen. Blood was 
immediately centrifuged at 5.000 rpm for 6 minutes. Serum supernatant was stored at -80°C until analysis. 
 
Animal treatment. ITPP was synthesized as previously described
(13)
 and i.v. injected 30 min. prior to 
hepatectomy at 500 mg/kg as a solution (100 µl total volume) containing calcium chloride to balance its 
chelating effects.
(14)
 Controls received 100 µl 0.9% saline. αHif2a-siRNA and control siRNA were designed & 
validated by Axolabs Gmbh (Kulmbach, D) and packed into company-owned formulations preferentially 
targeting murine hepatocytes. We have confirmed preferential targeting in regenerating hepatocytes.
(3)
 Aha1 was 
chosen as an internal control knockdown, because it does not yield any phenotype in vivo (Axolabs, pers. 
comm.) and has no apparent impact on liver regeneration.
(3)
 Formulations were i.v.injected 48 hours before 
hepatectomy. Controls received PBS. Serum liver injury markers were assessed following all treatments to 
ascertain the lack of significant toxicity. 
 
Enzyme-linked immunosorbent assays. ELISAs for Vegf were from R&D Systems (Minneapolis, USA, 
DY493,  and for Hif1a/Hif2a from NewLife BioChemEX (Bethesda, MD, E90798Mu/E93466Mu). Triplicate 
measurements were performed. NE-PER Nuclear and Cytoplasmatic Extraction reagents (Thermo Fisher 
Scientific, Waltham, MA, PK207589) were used to isolate respective subcellular fractions. Separation of 
cytosolic and nuclear fractions was ascertained through immunoblots
(2)
 for lamin (Santa Cruz Biotechnology, 
Dallas, TX, sc-377001) and -tubulin (Cell Signaling, Allschwil, CH, 2128S).  
 
Immunohistochemistry. Antigens were retrieved by citrate boiling of 3-µm archived liver sections. Stainings 
were performed following standard protocols. Secondary detection was done using the Ventana Discovery 
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automated staining system and the iView DAB kit (Ventana Medical Systems, Tucson, AZ). Antibodies used 
were: Hif2a (Abcam, Cambridge, MA, ab199), Hif1a (LifeSpan BioSciences, Seattle, WA, LS-B495), Ki67 
(Cell Marque Lifescreen Ltd., Rocklin, CA, CMC27531021), pH3 (Abcam, Cambridge, MA, ab92628) and VE-
cadherin (Abcam, ab33168). Pimonidazole stainings (Hypoxyprobe Plus Kit, Hypoxyprobe™, NPI Inc., 
MA/USA) were done by Sophistolab AG (Muttenz, CH) according to provided instructions. Cell P Analysis 
software (Olympus, Volketswil, CH) was used for the quantification (per high power field) of positive nuclei and 
of pimonidazole staining in histological sections. Microvessel density was calculated through the area of VE-
cadherin-positive sinusoids (ImageJ software), as this approach has been found an accurate index of 
vascularization .
(15)
 
 
Quantitative Real-Time Polymerase Chain Reaction (qPCR). Total RNA was extracted from 50 mg of tissue 
using Trizol reagent (Invitrogen, Basel, Switzerland). qPCR was performed on cDNA (Thermo Script reverse 
transcription PCR System, Invitrogen) using an ABI Prism 7500 Sequence Detector system (PE Applied 
Biosystems Rotkreuz, Switzerland). TaqMan gene expression assays for Vegfa (Mm01281449_m1), Foxm1 
(Mm00514924_m1), Ccna2 (Mm00438063_m1), Ccnb2 (Mm00438063_m1), Cdkn1a (Mm00432448_m1), 
Angpt2 (Mm00545822_m1), Tgfb1 (Mm 01227699_m1), endothelial control Ld1 (Mm 00775963_m1), and the 
normalization control 18S rRNA (TaqMan control reagents) were from PE Applied Biosystems (Massachusetts, 
USA). Results represent mean fold induction (2
-Ct
) ±SD.  
 
Statistical analysis. Data are presented as mean with error bars referring to ±SD. Differences between groups 
were assessed by a two-tailed t-test assuming unequal variance. Six mice/group were analyzed unless otherwise 
stated. Differences were considered significant at P<0.05. Analyzes were performed using Prism 6.0 (GraphPad). 
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Results 
 
Treatment with antihypoxic inositol trispyrophosphate delays liver regeneration 
 
To prevent a development of hepatic hypoxia after resection, we applied the novel antihypoxic molecule inositol 
trispyrophosphate (ITPP). ITPP acts as an allosteric effector of hemoglobin, increasing dissociation of O2 from 
heme under low oxygen tension.
(13)
 ITPP efficiently promotes in vivo oxygenation of hypoxic tissues, an effect 
that lasts for about two days following injection.
(16)
 Furthermore, it suppresses Hifs along with the hypoxic 
response, and displays discernable toxicity neither in animals
(14, 17-19)
 nor humans (http://droia.be/droiacs.html).  
 
We injected ITPP 30 min. before hepatectomy, a period sufficient to inhibit tumor hypoxia without affecting 
normoxic tissues.
(18)
 To assess regeneration, liver-to-body-weight ratio (LW/BW) was measured at various times 
after resection. Liver weight regain was significantly delayed between 48h and 96h post hepatectomy in ITPP-
treated animals but was comparable to saline controls towards the end of the regenerative process (Fig. 1A). 
Counting of hepatocytes in cycle (Ki67-positive) revealed no differences between ITPP and control animals (Fig. 
1B), suggesting entry into cell cycle is not affected.  However, bold nuclear pH3-positivity, marking mitotic 
hepatocytes,
(2)
 was reduced by ITPP at 48h (the M-phase peak in regenerating mouse liver) and was elevated at 
later times, consistent with the delayed liver weight gain and corroborated by mitotic counts on histology (Fig. 
1C/D). Therefore, ITPP treatment prior to hepatectomy causes a regenerative delay associated with deficient 
progression of hepatocytes through mitosis.  
 
Marked hypoxia develops with initial parenchymal expansion and correlates with Hif activity 
 
The antihypoxic properties of ITPP should reveal the presence of hypoxia in regenerating liver. The above 
experiments were repeated with mice pretreated with pimonidazole prior to sacrifice. To detect hypoxia, 
pimonidazle staining was compared between saline- and ITPP-treated mice at 2h to 96h after resection. For most 
times, including 2h, pimonidazole positivity was similarly weak. Significant differences were however noted at 
32h and 48h, with saline controls displaying marked hypoxic positivity, while hypoxia was suppressed in ITPP-
treated mice (Fig. 2A). The hypoxic window hence coincides with the parenchymal S- and M-phase peaks.
(2)
 
Next, we measured Hif1a and Hif2a expression. Their mRNA levels did not significantly change during the 
regenerative course (data not shown). When assessing hepatic protein levels by ELISA, Hif1a was elevated 
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during the first 48h post resection, however only in the cytosolic but not the nuclear fraction. Moreover, ITPP 
did not impact on Hif1a levels (Fig. 2B). In contrast, both cytosolic and nuclear Hif2a expression peaked at 32h 
and 48h post hepatectomy, with ITPP treatment significantly reducing Hif2a levels around these times (Fig. 2C, 
Supplementary Fig. 1). Therefore, Hif1a transcriptional activity is not promoted by hypoxia in regenerating liver, 
whereas Hif2a is stabilized and accumulates in hepatocyte nuclei during the hypoxic phase following tissue loss. 
Likewise, mRNA and protein expression of the Hif target Vegfa was elevated in saline controls but not ITPP-
treated mice at 32h/48h (Fig. 2D), suggsting that Hif2a, but not Hif1a, responds to regenerative hypoxia to 
induce Vegf production. Since Vegf is needed for the subsequent angiogenic phase in regenerating liver,
(4-6)
 we 
examined sinusoidal vasculature at days 2 to 5 after resection. At 48h, the sinusoidal network was poorly 
developed and no overt differences were noted between saline controls and ITPP mice. At days 3 to 5 however, 
sinusoids were prominent in saline controls, but remained marginal in ITPP mice (Fig. 2E). Altogether, these 
data reveal a consistent correlation between the presence of hypoxia, the activation of Hif2a, the promotion of 
hepatocyte mitosis, the production of Vegf, and the subsequent reconstitution of the sinusoidal network in 
regenerating liver.  
 
Hif2a deficiency mirrors the regenerative delay seen following hypoxic inhibition via ITPP 
 
The hypoxia-dependent upregulation of Hif2a and associated changes imply critical function for the molecule in 
regeneration. In liver, regenerative pathways often act in redundant ways to ensure completion of regeneration 
also under suboptimal conditions.
(20)
 To perform a loss of Hif2a function experiment, we chose an acute 
knockdown approach rather than genetic deletion, as to minimize compensatory mechanisms.
(20)
 Additionally, 
silencing may better mimic ITPP effects, because it does not suppress expression completely. We transfected 
mice with siRNA using a delivery formulation that in our hands preferrentially targets hepatocytes.
(3)
 
 
Mice were injected with siRNA against Hif2a or the internal control Aha1 prior to hepatectomy and analyzed. 
αAha1-siRNA did not reduce Hif2a levels after resection. In contrast, αHif2a-siRNA efficiently inhibited the 
cytosolic and nuclear Hif2a peaks in regenerating liver (Fig. 3A, Supplementary Fig. 1). During these times, 
αHif2a-siRNA had no impact on Hif1a expression relative to Aha1-controls (Fig. 3B), although transfection 
appeared to elevate cytosolic levels relative to ITPP/saline treatment (Fig. 2B).  
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When assessing LW/BW, Hif2a knockdown markedly delayed liver weight regain after resection (Fig. 3B). 
Compared to ITPP (Fig. 1B), the delay in regeneration was extended for about a day, likely due to the more 
pronounced nuclear Hif2a downregulation through αHif2a-siRNA than ITPP around the hypoxic peak (Fig. 
3B/2C). Otherwise, the regenerative defect was qualitatively similar; both Hif2a knockdown and ITPP caused 
delayed liver weight regain apparent between 48h and 96h post hepatectomy, implying Hif2a is a crucial 
mediator of the impact hypoxia has on liver regeneration.   
 
Hif2a promotes hepatocyte mitosis in regenerating liver 
 
Next we assessed whether Hif2a knockdown prior to hepatectomy affects proliferative parameters similar to 
those seen after ITPP treatment. Following Hif2a relative to Aha1 knockdown, no significant differences were 
noted for Ki67 counts (Fig. 4A). Akin to ITPP-treated mice, bold nuclear pH3 positivity and mitoses were 
reduced around the mitotic peak through Hif2a knockdown. However, the re-elevation of pH3/mitotic counts 
was delayed after knockdown compared to ITPP treatment (Fig. 1C/D), reflecting the prolonged delay in 
LW/BW regain following Hif2a silencing (Fig. 3C/1A). To confirm a defect in mitotic progression, we measured 
expression of Foxm1,  an essential promoter of the hepatocyte S- and particularly M-phase after resection.
(21)
 
ITPP treatment suppressed the mitosis-associated peak of Foxm1 along with its downstream targets Ccdna2 
(cyclin A) and Ccdnb2 (cyclin B), while upregulating its negative target Cdkna1 (the cell cycle inhibitor p21) 
(Fig. 4B).
(21)
 Similar expression alterations were observed upon Hif2a knockdown relative to Aha1 controls. 
Therefore, Hif2a deficiency phenocopies the mitotic defects associated with ITPP treatment. Together with the 
similar delay in liver weight gain after hepatectomy and the inhibition of Hif2a nuclear accumulation through 
ITPP, we conclude that Hif2a activation mediates the mitotic effects hypoxia has on hepatocytes.    
 
Hif2a upregulates hepatocellular Vegf production to induce the angiogenic phase in regenerating liver 
 
Hif2a activity during the hypoxic phase in regenerating liver is likely responsible for the elevations in Vegf 
observed during this time window. We measured hepatic mRNA and serum protein levels of Vegf following 
Hif2a knockdown and hepatectomy. αAha1-siRNA-treated controls displayed both Vegf mRNA and protein 
increases around the mitotic peak (Fig. 5A), akin to saline-treated mice (Fig. 2D). In contrast, both mRNA and 
protein elevations were suppressed by Hif2a knockdown (Fig. 5A), again mirroring the effects seen with ITPP 
treatment (Fig. 2D). When examinig vasculature at 48h to 120h after hepatectomy, reconstitution of the 
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sinusoidal network was apparent in Aha1 controls, but was defective in the αHif2a-siRNA-treated animals (Fig. 
5B). To substantiate a functional deficiency in vessel formation, we measured microvessel density (MVD) after 
Hif2a knockdown. Knockdown suppressed the raises in MVD seen in controls after 48h, similar to ITPP (Fig. 
5C). Furthermore, to assess angiocrine function, we measured the expression of endothelial Angpt2, important 
for sinusoidal proliferation,
(7) 
and its endothelial downstream target Tgfb1, a key angiocrine signal required for 
the termination of parenchymal regeneration.
(7) 
At 48h after resection, Hif2a knockdown - akin to ITPP - had no 
impact on Angpt2 and Tgfb1. In contrast, both Hif2a knockdown and ITPP impaired the upregulation of Angpt2 
and Tgfb1 seen in controls at 120h following hepatectomy. Altogether, these findings indicate that Hif2a activity 
is required to induce Vegf production and the subsequent angiogenic phase for the regeneration of SECs.  
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Discussion 
 
Intense exchange between hepatocytes and circulating blood is key to liver function.  Exchange is enabled 
through the specific liver architecture, where each hepatocyte lines an endothelial cell of the sinusoidal network. 
The intimate bonds between hepatocytes and SECs, combined with the profound changes in hepatic blood flow 
following tissue loss, have fostered  the view that declines in oxygen levels may influence the regenerative 
process. Thus far, direct evidence for a role of hypoxia in liver regeneration was lacking. In this study, we show 
that after hepatectomy, (i) significant hypoxia develops with parenchymal growth and is required for efficient 
liver recovery; (ii) the hypoxic phase leads to hepatocellular Hif2a, but not Hif1a, activation;  (iii) Hif2a 
promotes the progression of hepatocytes through mitosis; and (iv) Hif2a in parallel induces the major wave in 
Vegf needed for the subsequent reconstitution of the sinusoidal network.   
 
To explore the role for oxygen in the regulation of liver regeneration, we took advantage of the nontoxic 
antihypoxic molecule ITPP. Acting on hemoglobin, ITPP promotes the oxygenation of hypoxic tissue without 
apparent effects on well-oxygenated regions.
(13, 18)
 Consequent to its dependence on hemoglobin, ITPP seems to 
lack direct effects on cells. Testing ITPP on epithelial cell cultures, we have not observed any effects on 
proliferation, cell death, mitochondrial/glucose metabolism, and migration.
(16)
 Therefore, ITPP represents a 
unique tool to study the impact a hypoxic environment has on biological processes in vivo.  
 
ITPP treatment delayed liver regeneration during a period which we have previously shown to be associated with 
deficient hepatocyte mitosis.
(2)
 Notably, early time points were not affected (i.e. weight gain, Ki67), suggesting 
that immediate hypoxia - as postulated based on portal flow changes
(1)
 - plays a minor, if any, role in the 
regulation of liver regeneration. We detected only small difference in pimonidazole staining at 2h after resection, 
implying immediate hypoxia may be mild. Instead, distinct hypoxia was detectable between 24h and 48h, when 
sinusoidal density is known to be lowest (see also Fig. 5C & Supplementary Fig. 2) and hepatocyte proliferation 
is peaking.
(6, 20, 22)
 Conceivably, the selective expansion of parenchyme is the cause of tissue hypoxia, akin to 
what is known from tumors. In turn, parenchymal hypoxia activates Hif2a, which, as shown by the comparison 
with ITPP and knockdown, promotes the progression of hepatocytes through mitosis.  
 
Notably, ITPP is considered for the treatment of malignancy,
(14-17)
 and we have initiated the first clinical trial of 
ITPP in cancer patients (NCT02528526). In experimental colorectal liver metastasis, we have observed a marked 
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inhibitory effect of ITPP and demonstrated its ability to potentiate standard chemotherapy.
(16) 
ITPP hence might 
be used for the downstaging of liver tumors to enable resection. Here, our current findings suggest that ITPP 
treatment would need cessation before resection, as otherwise patients may be put at risk of resection-induce 
liver failure. Indeed, when performing an extended (86%) hepatectomy inducing mild liver failure,
(2)
 prior ITPP 
treatment increases mortality from 20% to 100% (Supplementary  Fig. 3), demonstrating the associated risk of 
postoperative liver failure. On the other hand, these findings also demonstrate the potent proregenerative 
function
(2)
 hypoxia has after tissue loss.  
 
As a limitation of our study, only one siRNA was used for knockdown; we hence cannot exclude off target 
effects. However, the strongly homologous Hif1a
(8)
 was unaffected by Hif2a knockdown. Furthermore,  Hif2a 
suppression by either knockdown or ITPP treatment had very similar outcomes across all investigated 
parameters related to liver weight gain, cell cycle progression and endothelial regeneration. Therefore, the sum 
of evidence implies that the main phenotype observed after knockdown is dependent on Hif2a. Finally, siRNA 
effects on extrahepatic tissues and non-parenchymal liver cells are likely minimal, because our transfectant 
preferentially targets hepatocytes,
(3)
 and because nuclear Hif2a expression appeared to be low and unaffected by 
knockdown in both, other tissues (Supplementary Fig. 1) and non-parenchymal cells (Supplementary Fig. 4).  
 
Our observation that Hif2a, but not Hif1a, mediates hypoxia-driven proliferation in regenerating liver is not 
unexpected. Diseases typified by HIF overactivity due to mutation in the HIF-degrading enzyme VHL present 
with hepatomegaly and hypervascularity, both of which have been attributed to HIF2A but not HIF1A.
(23, 24)
 
Moreover, during early liver organogenesis, zebrafish Hif2a, but not Hif1a, promotes hepatocyte proliferation 
required for the provision of the future parenchyme mass,
(25)
 suggesting the mitotic function of HIF2A is 
conserved in liver. Puzzlingly, Hif1a knockout does delay liver regeneration in mice. However, Hif1a also 
regulates glucose metabolism after resection, with delayed regeneration perhaps being an indirect effect related 
to a perturbed energy metabolism.
(9)
 Furthermore, we measured very low Hif1a nuclear levels that were 
unresponsive towards  ITPP-induced oxygenation changes. The reasons for the low hepatic Hif1a expression are 
unclear, however Hif1a levels may be suppressed by miR122, the most abundant microRNA in liver.
(26)
 
Consistent with its marginal nuclear expression, Hif1a - unlike Hif2a - does not react to hypoxia-reoxygenation 
in hepatocyte cultures.
(27)
 We hence conclude that Hif2a, but not Hif1a, is a main mediator of the hypoxic 
response in regenerating liver.    
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An intriguing finding of this study is the dual fuction of Hif2a. Its genetic or antihypoxic inhibition not only 
suppressed the peak of hepatocyte mitosis, but also abrogated the dominant wave of Vegf elevations in 
regenerating liver. As shown in previous studies,
(4, 5, 27)
 the Vegf wave is essential for sinusoidal regeneration and 
is sourced from replicating hepatocytes. Therefore, hypoxia developing from parenchymal regeneration 
functions in analogy to tumor-associated hypoxia, inducing Vegf as to re-install blood supply. Hif2a in turn 
provides a simple mechanism to combine Vegf production with hepatocellular proliferation. This parallel 
regulation of hepatocyte mitosis and the subsequent angiogenic phase identifies Hif2a as a central node in 
coordinating the regeneration of different liver cell populations. By coupling hepatocyte mitosis to Vegf 
production, Hif2a appears to act as a safeguard to permit the course of the angiogenic phase only upon successful 
parenchymal growth. Regenerative hypoxia and Hif2a are hence necessary to imprint a timely order onto cell-
type specific regeneration patterns. This timing of hepatocyte and SEC proliferation however can be overruled, 
since after Hif2a knockdown, liver eventually grows back to its original size, revealing the presence of 
compensatory mechanisms that are securing vital liver function. Interestingly, Hif2a knockdown and ITPP 
suppressed the upregulation of endothelial Tgfb1, active late after hepatectomy to terminate hepatocyte 
proliferation.
(1), (7)
 It is hence tempting to speculate that failed Tgfb1 upregulation is a crucial event enabling the 
late-phase compensatory parenchymal growth seen after Hif2a knockdown or ITPP treatment.  
 
The interplay between hepatocytes and SECs though Hif2a integrates into the previously described relationships 
between parenchymal and endothelial regeneration. Angiocrine signals from SECs are essential for the 
induction, progression and completion of liver regeneration. Via early Vegf signaling, SECs provide Hgf and 
Wnt2 to induce parenchymal regeneration.(
6, 28)
 Moreover, Vegf stimulates parenchymal proliferation also via 
hepatocellular Vegfr1 engagement.
(28) 
Through downregulation of Angpt2, SECs further hinder their own 
proliferation and lower production of Tgfb1, the key inhibitor of hepatocyte proliferation.
(7)
 Following the major 
phase of parenchymal growth, intensified Vegf signaling is needed for SEC proliferation.
(6)
 The concomitant re-
elevations in Angpt2 facilitate sinusoidal regeneration and upregulate Tgfb1 to cease hepatocyte proliferation.
(7)
 
Thus, two separate angiocrine phases exist that are characterized by divergent signaling to hepatocytes. Via 
Hif2a, the growing hepatocyte mass produces the Vegf amounts needed for SEC proliferation, thereby providing 
a link between the two distinct angiocrine phases. The hypoxia-driven Hif2a signaling illustrates the conceptual 
simplicity behind the timely coordination of hepatocyte-SEC regeneration after tissue loss, perhaps reflecting the 
evolutionary need to first replicate the functional units of liver, the hepatocytes, and then the sinusoids as a 
simple consequence of the developing tissue hypoxia. In summary, our findings portray the hypoxia-induced 
14 
 
 
Hif2a-Vegf axis as a prime regulator of the regenerative SEC-hepatocyte crosstalk and reveal a crucial role for 
oxygen during liver regeneration.  
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Figure legends 
 
Figure 1. Treatment with ITPP delays liver regeneration after hepatectomy. (A) Liver-to-body weight ratio 
(LW/BW) in saline- and ITPP-treated mice after resection. Counts of (B) hepatocytes with nuclear Ki67-
positivity, of (C) hepatocytes with bold nuclear pH3-positivity, and of (D) mitotic hepatocytes on histology in 
liver of saline/ITPP-treated mice. Note the re-elevation in pH3/mitotic counts at later time points, consistent with 
the accelerated liver weight regain at 120h post resection in ITPP-treated mice. N=6 mice/group. *P<0.05, 
**P<0.005.  
 
Figure 2. ITPP treatment inhibits hypoxia, Hif2a activation, Vegf production and sinusoidal reconstitution after 
hepatectomy. (A) Quantification of pimonidazole staining in liver from saline/ITPP-treated mice between 2h and 
96h after hepatectomy, with representative stainings shown below. (B) Hif1a and (C) Hif2a cytosolic (top) and 
nuclear (bottom) protein levels in liver from saline/ITPP-treated mice after resection. (D) Vegf hepatic mRNA 
and serum protein levels in saline/ITPP-treated mice after resection. (E) VE-cadherin staining of the sinusoidal 
network between 48h to 120h after resection. Note the paucity of vessels in both saline (cont) and ITPP-treated 
liver at 48h post resection. For better visualization, image colors unrelated to brown were desaturized. N=6 
mice/group. *P<0.05, **P<0.005.  
 
Figure 3. Hif2a knockdown and its impact on liver weight gain after hepatectomy. (A) Cytosolic (top) and 
nuclear (bottom) Hif2a levels in liver from αAha1-siRNA (Aha1) or αHif2a-siRNA-treated mice after 
hepatectomy. (B) Cytosolic (top) and nuclear (bottom) Hif1a levels in liver after Hif2a/Aha1 knockdown and 
resection. (C) Liver weight gain (LW/BW) following Hif2a/Aha1 knockdown and hepatectomy. Note the 
prolonged delay in weight regain after Hif2a knockdown relative to ITPP treatment (Fig. 1C), consistent with the 
stronger Hif2a suppression through knockdown than ITPP (Fig. 2C). Aha1 knockdown somewhat prolonged 
nuclear Hif2 elevation, however without effect on LW/BW. N=6 mice/group. *P<0.05, **P<0.005.    
 
Figure 4. Hif2a deficiency inhibits progression through mitosis in regenerating liver. (A) Counts of hepatocytes 
positive for Ki67, pH3, or undergoing mitosis in liver of mice following Hif2a/Aha1 knockdown and 
hepatectomy. N=6 mice/group. (B) Relative expression of genes encoding Foxm1, cyclin A, cyclin B, and p21 
during the first 4 days after hepatectomy. Expression is shown for ITPP/saline-treated mice (left graphs) and for 
αHif2a-siRNA/αAha1-siRNA-treated mice (right graphs). N≥3 mice/group. *P<0.05, **P<0.005.     
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Figure 5. Hif2a induces Vegf production for sinusoidal reconstitution in regenerating liver. (A) Hepatic Vegf 
mRNA and serum protein levels following Hif2a/Aha1 knockdown and hepatectomy. (B) VE-cadherin staining 
of sinusoidal vessels between 48h to 120h after knockdown and resection. (C) Microvessel density after 
Hif2a/Aha1 knockdown and hepatectomy in comparison to ITPP and saline treatment. (D) Relative expression of 
genes encoding endothelial Angpt2 and Tgfb1 after hepatectomy. ITPP/saline treatment is shown to the left, 
Hif2a/Aha1 knockdown to the right. Expression values were normalized to a generic control (upper panels) or to 
an endothelial control (Id1, see ref. 7).  The similar expression patterns are consistent with the reported 
expression of Angpt2-Tgfb1 on endothelial cells. N=6 mice/group. *P<0.05, **P<0.005. 
 
 
